Skip to content
ClinCalc Pro
Menu
Ocular lubricant (hyaluronic acid)

Sodium hyaluronate

Brand names: Hylo-Forte, Hylo-Care, Clinitas

Sodium hyaluronate is a naturally occurring glycosaminoglycan used in ophthalmology as an ocular lubricant in eye drops for dry eye disease and as an ophthalmic viscosurgical device during intraocular surgery.

Not a dosed medicine

Use as directed by the product's instructions, and check your local formulary.

Clinical monograph

How it works

Its high molecular weight and water-binding capacity allow it to retain moisture on the ocular surface and form a stable, viscoelastic protective film over the cornea and conjunctiva.

Prescribing in practice

  • Many lubricant formulations are preservative-free or contain preservatives that can cause ocular surface toxicity with frequent or long-term use, so a preservative-free product is preferred for chronic dosing or in preservative-sensitive patients.
  • May be instilled as often as required for symptom relief and is generally well tolerated.
  • If multiple eye drops are used, separate instillation of different drops and apply ointments last.

Monitoring

No systemic monitoring is required; review symptom control and ocular surface health clinically and reassess if irritation or worsening symptoms occur.

Counselling the patient

  • Transient blurring of vision may occur immediately after instillation, so wait until vision clears before driving.
  • Remove soft contact lenses before instilling unless the product is specifically licensed for use with lenses, and follow the manufacturer's discard date once opened.

Evidence & guidelines

Ocular lubricants are recommended as first-line therapy for dry eye disease in clinical guidance such as NICE Clinical Knowledge Summaries.

Reference: RCOphth; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.